The article offers developments related to the bioethics associated with end-stage renal disease (ESRD) in the U.S. The topics discussed include the legislation passed by Congress on October 30, 1972 that authorized the treatment of ESRD under Medicare, the shared decision making of patients and their families related to end-of-life care, and the palliative care techniques for ESRD.